Ronald Buckanovich
2 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Vismodegib Combined With Atezolizumab in Platinum Resistant Ovarian, Fallopian Tube, and Primary Peritoneal Cancer (NCT05538091) | Ronald Buckanovich | 2023-05-15 |
Track Ronald Buckanovich automatically
Every clearance here is in the API, with alerts when new ones post.